Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024

Company to Also Participate in 2024 Wedbush PacGrow Healthcare Conference RESEARCH TRIANGLE PARK, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company,

By: financialpost.com

Aug 06 2024
30
14220 Views

Company to Also Participate in 2024 Wedbush PacGrow Healthcare Conference Read More

New Yorkers are warned from the skies about impending danger from storms as city deploys drones

Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc.

Stingray Reports First Quarter Results for Fiscal 2025

Maxim Power Corp. Announces 2024 Second Quarter Financial and Operating Results

Magellan Aerospace Corporation Announces Financial Results

American Hotel Income Properties REIT LP Reports Q2 2024 Results With 5.1% RevPAR Growth

Orezone Reports Second Quarter 2024 Results

Melcor Developments announces second quarter results, declares quarterly dividend of $0.11 per share

Dream Industrial REIT Reports Strong Q2 2024 Financial Results and Announces Over 500,000 Square Feet of Development Leasing

Kneat Announces Record Revenue for Second Quarter 2024

Algoma Steel to Announce Fiscal 2025 First Quarter Results August 13, 2024

Firm Capital Property Trust Reports Q2/2024 Results

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Get Reliable Matka Guessing Forum with our Satta Matka Expert and Get all Matka Chart For Free.

Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024

Related